Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. IMD-7-2163
Authors: Bettina Buechel
Published by: International Institute for Management Development (IMD)
Originally published in: 2020
Version: 18.03.2020
Revision date: 08-Jun-2020
Length: 9 pages
Data source: Field research

Abstract

In 2018, Roche Diagnostics created an open innovation platform through a global Silicon Valley based eco-system venture fund, Plug & Play to have access to a screened portfolio of start-ups in the digital health care solution domain. This enabled the company to create links between strategic priorities (point of care solutions, molecular diagnostics, diabetes care and tissue diagnostics) and start-ups focusing on digital healthcare innovations. There were a number of challenges to overcome - ranging from acceptance of the business to work with start-ups, setting legal frameworks that would allow collaboration between the business and the start-ups and ultimately converting the results of the three-months collaboration projects into ongoing contracts that would ultimately lead to new solutions that could be offered in the market. While the initial collaboration between the business and the start-ups over shorter periods of time worked, the scaling of the collaboration and the establishing of the business model for joint value creation still had to be worked out.

Time period

The events covered by this case took place in 2018-2020.

Geographical setting

Region:
World/global
Country:
Switzerland

Featured company

Roche Holding
Turnover:
CHF 57 billion
Industry:
Pharmaceuticals

About

Abstract

In 2018, Roche Diagnostics created an open innovation platform through a global Silicon Valley based eco-system venture fund, Plug & Play to have access to a screened portfolio of start-ups in the digital health care solution domain. This enabled the company to create links between strategic priorities (point of care solutions, molecular diagnostics, diabetes care and tissue diagnostics) and start-ups focusing on digital healthcare innovations. There were a number of challenges to overcome - ranging from acceptance of the business to work with start-ups, setting legal frameworks that would allow collaboration between the business and the start-ups and ultimately converting the results of the three-months collaboration projects into ongoing contracts that would ultimately lead to new solutions that could be offered in the market. While the initial collaboration between the business and the start-ups over shorter periods of time worked, the scaling of the collaboration and the establishing of the business model for joint value creation still had to be worked out.

Settings

Time period

The events covered by this case took place in 2018-2020.

Geographical setting

Region:
World/global
Country:
Switzerland

Featured company

Roche Holding
Turnover:
CHF 57 billion
Industry:
Pharmaceuticals

Related